Nanoscintillation Systems for Aqueous-Based Liquid Scintillation Counting by Mumper, Russell J. & Jay, Michael
University of Kentucky
UKnowledge
Pharmaceutical Sciences Faculty Patents Pharmaceutical Sciences
2-15-2005
Nanoscintillation Systems for Aqueous-Based
Liquid Scintillation Counting
Russell J. Mumper
University of Kentucky
Michael Jay
University of Kentucky
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/ps_patents
Part of the Pharmacy and Pharmaceutical Sciences Commons
This Patent is brought to you for free and open access by the Pharmaceutical Sciences at UKnowledge. It has been accepted for inclusion in
Pharmaceutical Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Recommended Citation
Mumper, Russell J. and Jay, Michael, "Nanoscintillation Systems for Aqueous-Based Liquid Scintillation Counting" (2005).
Pharmaceutical Sciences Faculty Patents. 76.
https://uknowledge.uky.edu/ps_patents/76
US006855270B2 
(12) United States Patent (10) Patent N0.: US 6,855,270 B2 
Mum er et al. 45 Date of Patent: Feb. 15 2005 a 
(54) NANOSCINTILLATION SYSTEMS FOR 5,298,197 A 3/1994 Thompson ................ .. 252/700 
AQUEOUS_BASEI) LIQUID SCINTILLATION 5,410,155 A 4/1995 Thomson et al. . 250/364 
COUNTING 5,503,781 A 4/1996 Sumii et al. ........ .. 264/4.7 
5,512,753 A 4/1996 Thomson et al. ......... .. 250/361 
. - 5,726,456 A 3/1998 Lupton et a1. ....... .. 252/182.21 (75) Inventors. Russell J. Mumper, Lexington, KY . . 
(Us); Michael Jay, Lexington, KY 5,879,715 A 3/1999 Higgins et a1. ........... .. 424/489 
(US) FOREIGN PATENT DOCUMENTS 
(73) Assignee: The University of Kentucky Research Foundation, Lexingto , KY (US) W0 WO 01/78689 10 0001 
( * ) Notice: Subject to any disclaimer, the term of this OTHER PUBLICATIONS 
Pawnt is extended or adjusted under 35 Bargoni et al., “Solid lipid nanoparticles in lymph and 
U-S-C- 154(k)) by 25 days- plasma after duodenal administration to rats,” Pharmaceu 
tical Research, 15:745—750, 1998. 
(21) Appl. No.: 10/165,201 Cavalli et al., “Study by X—ray poWder diffraction and 
differential scanning calorimetry of tWo model drugs, phe 
(22) Filed: Jun‘ 6’ 2002 nothiaZine and nifedipine, incorporated into lipid nanopar 
(65) Prior Publication Data ticles,” Eur J. Pharm. Biopharm, 41(5):329—333, 1995. 
Cavalli et al., “The effect of the components of microemul 
US 2004/0178388 A1 SeP' 16’ 2004 sions on both siZe and crystalline structure of solid lipid 
_ _ nanoparticles (SLN) containing a series of model mol 
_ _ Relatul U15‘ APPhcatlO“ Data ecules,” Pharmazie, 53(6):392—396, 1998. 
(60) gggilslonal apphcanon NO‘ 6O/296’124’ ?led on Jun‘ 7’ De and Hoffman, “An ophthalmic formulation of a Beta—a 
' drenoceptor anatgonist, levobetaXolol, using Poly(acrylic 
(51) Int. Cl? .............................................. .. C09K 11/02 if)”;:21’;ggijjvgsafgrgggfjgzgg 55323535323353; 
(52) US. Cl. ............ .. 252/301.17; 250/364; 250/361 R; 2001 ’ ' ’ 
250/483.1; 252/646; 252/644; 252/645 ' _ _ 
(58) Field of Search .......................... .. 252501.17, 646, (L1St Con?rmed on next Page) 
252/644, 645; 250/364, 361 R, 483-1 Primary Examiner—C. Melissa KosloW 
(74) Attorney, Agent, or Firm—Fulbright & J aWorski LLP 
(56) References Cited 
(57) ABSTRACT 
U.S. PATENT DOCUMENTS 
The present invention relates to the use of nanoscintillation 
2 1;; sDrexhatgel ~~~~~~~~~~~~~~~~ systems, or nanoparticles containing ?uor molecules, that 
’ ’ ena e a ' " ' can be used to detect an electron-emitting or alpha-particle 
:;:;:;2:;‘ 2 3:22: ::::::: 1: 13554228 of 4,127,499 A 11/1978 Chen et aL 25260117 commonly used'm orgamc-based l1qu1d scmtillatlon cock 
4’358’401 A 11/1982 O’Brien et a1_ _ _________ __ 588/8 tails. The invention also relates to compositions and use of 
4,522,742 A 6/1985 Lee et a1_ _____ __ 25250116 three oil-in-Water microemulsion precursors that can be 
4,588,698 A 5/1986 Gruner et al. .. ...... .. 436/535 engineered rapidly, reproducibly, and cost-effectively to 
4,624,799 A 11/1986 Hegge et al 252/301-17 produce useful nanoparticles less than 100 nanometers. 
4,710,319 A 12/1987 Lee et al. 252/646 
5,250,236 A 10/1993 Gasco ...................... .. 264/44 40 Claims, 6 Drawing Sheets 
250 
200 . 40 
E, 1504 
.3 
m 
100 - 
f‘; 45 
1: 
e 50' 
(Cu 
2 
O . . . . . t r t . v . v 
024681012141618202224265O 
Polyoxyl 20 Stearyl Ether (mM) 
in Microemulsion Nanotemplates 
US 6,855,270 B2 
Page 2 
OTHER PUBLICATIONS 
Morel et al., “Thymopentin in solid lipid nanoparticles,” 
International J. of Pharmaceutics, 132:259—261, 1996. 
Sharma et al., “Novel taXol formulation: polyvinylpyrroli 
done nanoparticle—encapsulated taXol for drug delivery in 
cancer therapy,” Oncology Research, 8(7/8):281—286, 1996. 
UgaZio et al., “Incorporation of cyclosporin A in solid lipid 
nanoparticles (SLN),” International J. of Pharmaceutics, 
241:341—344, 2002. 
Utreja et al., “Lipoprotein—mimicking biovectoriZed sys 
tems for methotreXate delivery,” Pharmaceutica Acta Hel 
vetiae, 73:275—279, 1999. 
Agostiano et al., “Synthesis and structural characterisation 
of CdS nanoparticles prepared in a four—components 
“Water—in—oil” microemulsion,” Micron, 31:253—258, 2000. 
AttWood, “Microemulsions,” In: Colloidal Drug Delivery 
Systems, Kreuter (ed.), 31—71, 1994. 
Bhargava et al., “Using microemulsions for drug delivery,” 
Pharm. Tech., 46—53, 1987. 
Bocca et al., “Phagocytic uptake of ?uorescent stealth and 
non—stea1th solid lipid nanoparticles,” International Journal 
ofPharmaceutics, 175:185—193, 1998. 
Capek, “Microemulsion polymerization of styrene in the 
presence of anionic emulsi?er,” Advances in Colloid and 
Interface Science, 82: 253—273, 1999. 
Cavalli et al., “Solid lipid nanoparticles as carriers of 
hydrocortisone and progesterone complexes With cyc1odeX 
trins,” International Journal of Pharmaceutics, 182:59—69, 
1999. 
Constantinides, “Lipid microemulsions for improving drug 
dissolution and oral absorption: physical and biopharmaceu 
tical aspects,” Pharm. Res., 12:1561—1572, 1995. 
EWer and Harding, “Micellar scintillators: A rational 
approach to the design of stable assay solvents for liquid 
scintillation counting,” In: Liquid Scintillation Counting. 
vol. 3. Crook and Johnson (eds.), Heyden & Son. London, 
pp. 220—233, 1974. 
Fang et al., “Nanocrystalline bismuth synthesiZed via an in 
situ polymeriZation microemulsion process,” Materials Let 
ters, 42:113—120, 2000. 
Goddu et al., “Spectrophotometric determination of esters 
and anhydrides by hydroXamic acid reaction,”Anal. Chem., 
27:1251—1255, 1955. 
Harrah and Powell, “Dose rate saturation in plastic scintil 
lators,” In: Organic Scintillators and Liquid Scintillation 
Counting, Horrocks and Peng (eds.), Academic Press. NeW 
York, p. 266, 1971. 
Ho et al., “Preparation of microemulsions using polyglyc 
erol fatty acid esters as surfactant for the delivery of protein 
drugs,” J. Pharm. Sci., 85:138—143, 1996. 
Hoar and Schulman, “Transparent Water—in—oil dispersions: 
the oleopathic hydro—micel1e,” Nature, 152:102—103, 1943. 
Horrocks, In: Applications of Liquid Scintillation Counting. 
Academic Press. NeW York. p. 16, 1964. 
Lade et al., “On the nanoparticle synthesis in microemul 
sions: detailed characteriZation of an applied reaction miX 
ture,” Collids and Surfaces A: Physicochemical and Engi 
neering Aspects, 163:3—15, 2000. 
Li and Park, “Particle siZe distribution in the synthesis of 
nanoparticles using microemulsions,” Langmuir; 
15:952—956, 1999. 
Meier, “Nanostructure synthesis using surfactants and 
copolymers,” Current Opinion in Colloid & Interface Sci 
ence, 4:6—14, 1999. 
Munshi et al., “Preparation and siZe modulation of drug 
loaded nanoencapsulated particles using microemulsion 
mediated method,” Journal of Controlled Release, 41:S7, 
Abstract #P7, 1997. 
Myers and Brush, “Counting of alpha and beta radiation in 
aqueous solutions by the detergent—anthracene scintillation 
method,” Analyt. Chem., 34:342—245, 1962. 
Porta et al., “Synthesis of spherical nanoparticles of 
Cu2L205 (L=Ho, Er) from W/O microemulsions,” Colloids 
and Surfaces A: Physicochemical and EngineeringAspects, 
160:281—290, 1999. 
Ruys and Mai, “The nanoparticle—coating process: a poten 
tial sol—gel route to homogenous nanocomposites,” Materi 
als Science and Engineering, A265:202—207, 1999. 
Schram, “F1oW—monitoring of aqueous solutions containing 
Weak [3— emitters,” In: The Current Status of Liquid Scin 
tillation Counting, Bransome (ed), Grune and Stratton. NeW 
York, pp. 95—109, 1970. 
Song and Kang, “Preparation of high surface area tin oxide 
poWders by a homogeneous precipitation method,” Materi 
als Letters, 42:283—289, 2000. 
Steinberg, “Radioassay of carbon—14 in aqueous solutions 
using a liquid scintillation spectrometer,” Nature, 
182:740—741, 1958. 
Tang et al., “Electrochemical synthesis of polyaniline nano 
particles,” Electrochemistry Communications, 2:32—35, 
2000. 
Tojo et al., “In?uence of reactant eXcess and ?lm ?exibility 
on the mechanism of nanoparticle formation in microemul 
sions: A Monte Carlo simulation,” Langmuir; 
14:6835—6839, 1998. 
Xiangling et al., “GroWth of polymer nanoparticles in micro 
emulsion polymerization initiated With ray,” Radiation 
Physics and Chemistry, 54: 279—283, 1999. 
U.S. Patent Feb. 15,2005 Sheet 1 0f 6 US 6,855,270 B2 
Figure 1 
m 
m g
m wo
2 4| 1
“E5 35 225352 
0 2 4 6 810121416182022242650 
Polyoxyl 2O Stearyl Ether (mM) 
in Microemulsion Nanotemplates 
U.S. Patent Feb. 15,2005 Sheet 2 0f 6 US 6,855,270 B2 
FigureZ 
8[)_ 
6O 
4O_ 
20* I 
0 I . 
Qm'nglmmd 
U.S. Patent Feb. 15,2005 Sheet 3 0f 6 US 6,855,270 B2 
Figure 3 
q l 
l | 
100 
w %E5 3  mBEmQocwz 
0 
A B 
Curing Method 
U.S. Patent Feb. 15,2005 Sheet 4 0f 6 US 6,855,270 B2 
Figure 4 
100 
5 O0
7 52
4.3 2.3 2.1 1.4 1.0 0.0 
Hnal Concentration of PPO in water (mg/nL) 
U.S. Patent Feb. 15,2005 Sheet 5 0f 6 US 6,855,270 B2 
Figure 5 
0.00 0.07 0.34 0.67 3.35 6.70 
_ mmmwo 21a. wmEEmQocmz 28 E5?w20:51 
Ratio of ASF-pal/Nanoparticles (w /w) 
U.S. Patent Feb. 15,2005 Sheet 6 6f 6 US 6,855,270 B2 
Figure 6 
Counts vs. Amount of Radioactivity 
100000 - 
160000 - 
140000- y= 10G1.1x~ 1778.1 
R2 = 069977 
120000 - 
100000 < . 
E O Cocktall (cpm) 
‘’ 80000 - . 
O Nanosuspenslon (cpm) 
00000 _ 
40000 6 
20000 > y = 272.37x + 466.57 
R = 0.9997 
0 . . . . . . . ? 
0 20 40 6O 80 10D 120 140 160 
“C-Acetic Acid Added (PLI 
US 6,855,270 B2 
1 
NANOSCINTILLATION SYSTEMS FOR 
AQUEOUS-BASED LIQUID SCINTILLATION 
COUNTING 
The patent application claims priority to US. Provisional 
Patent Application Serial No. 60/296,124 ?led Jun. 7, 2001 
entitled, “Nanoscintillation Systems for Aqueous-Based 
Liquid Scintillation Counting” by Russell J. Mumper and 
Michael Jay. That application is incorporated herein by 
reference in its entirety. 
Copending US. application Ser. No. 09/812,884 ?led 
Mar. 21, 2001 entitled, “Microemulsions as Precursors to 
Solid Nanoparticles” by Russell J. Mumper and Michael Jay 
is incorporated herein by reference in its entirety. 
FILED OF THE INVENTION 
This invention relates to nanotechnology and more par 
ticularly relates to the use of nanotechnology to overcome 
solubility problems in pharmaceutical drug delivery. 
The present invention relates to nanoparticles containing 
?uor molecules to detect beta-particle emitting radioisotopes 
Without the use of commonly employed organic-based scin 
tillation cocktails. Although organic solvent-based scintilla 
tion cocktails are ef?cient, the disposal of the large quanti 
ties of “mixed” (radioactive and organic) Waste generated by 
the use of these cocktails presents an economical and 
environmental challenge. Nanoscintillation systems, or 
nanoparticles containing ?uor molecules, can be engineered 
from three different oil-in-Water microemulsion precursors, 
permanently suspended in aqueous-based media, and used to 
detect electron or alpha-particle emitting radioisotopes in the 
absence of any organic-based solvents. 
BACKGROUND OF THE INVENTION 
As early as 1937, it Was observed that certain organic 
materials ?uoresced folloWing excitation from external 
sources. Approximately 10 years later, it Was demonstrated 
that radioactive sources could induce scintillations in aro 
matic solvents that contained certain solutes. These early 
beginnings of “liquid scintillation counting” led to rapid 
advances in counting instrumentation (most notably the 
coincidence method) and to the development of scintillation 
“cocktails”. Many of the solvent-?uor combinations devel 
oped during the early Work on scintillation cocktails are still 
in use today. Since most of the efficient ?uors Were non 
polar, organic aromatic compounds, the primary solvents 
used to solubiliZe the ?uors Were also non-polar and aro 
matic. Further desirable properties such as high energy 
transfer capabilities and favorable chemical characteristics 
(freeZing, boiling and ?ash points) led to the use of toluene 
and xylenes as the most Widely employed primary solvents 
in scintillation cocktails. 
The counting of aqueous samples containing [3_-emitting 
radionuclides presented challenges in the development of 
suitable cocktails. TWo approaches to overcoming the 
immiscibility of the aqueous samples and the organic cock 
tail solvents Were studied. The initial approach involved 
dispersing organic ?uor molecules in an aqueous solution 
that could be easily mixed With the aqueous sample to be 
counted. An examination of this approach reveals that sev 
eral strategies for dispersing ?uors Were attempted and that 
some success Was achieved. 
Steinberg described a scintillation counting system in 
Which a ?nely divided ?uor, e.g. anthracene crystals, Was 
dispersed in an aqueous solution (Steinberg. D. Radioassay 
of carbon-14 in aqueous solutions using a liquid scintillation 
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spectrometer. Nature. 182:740—741, 1958) By achieving 
intimate contact betWeen the sample and the ?uor, many 
problems related to insolubility of the sample in organic 
solvents or to chemical quenching Were eliminated. Myers 
and Brush reported the use of blue-violet grade anthracene 
particles coated With detergents as efficient systems for 
counting aqueous samples (Myers. L. S. Brush. A. H. 
Counting of alpha and beta radiation in aqueous solutions by 
the detergent-anthracene scintillation method. Analyt. 
Chem. 34:342—245, 1962) Work Was also carried out in 
Which a product knoWn as “Pilot B” Was employed; this 
product Was composed of a polyvinyltoluene host contain 
ing p-terphenyl and diphenylstilbene as ?uors (Harrah, L. 
A., PoWell, R. C. Dose rate saturation in plastic scintillators. 
In: Organic Scintillators and Liquid Scintillation Counting. 
Ed. D. L. Horrocks and C. T. Peng. Academic Press. NeW 
York. p. 266, 1971) Either beads or ?laments of Pilot B Were 
packed into vials and covered With aqueous solutions con 
taining [3_-emitting radionuclides. Reasonable counting ef? 
ciencies Were obtained With these systems. Detectors con 
taining suspended scintillators ultimately found usefulness 
in ?oW-through cells used to detect [3_-emitting radionu 
clides in liquid chromatography effluents (Schram, E. FloW 
monitoring of aqueous solutions containing Weak [3' emit 
ters. In: The Current Status of Liquid Scintillation Counting. 
Ed. E. D. Bransome. Grune and Stratton. NeW York. pp. 
95—109. 1970) Finally, a system employing the formation of 
micellar suspensions for scintillation counting Was reported 
by EWer, M. J., Harding, N. G. L. Micellar scintillators: A 
rational approach to the design of stable assay solvents for 
liquid scintillation counting. In: Liquid Scintillation Count 
ing. Volume 3. Ed. M. A. Crook and P. Johnson. Hevden & 
Son. London. pp. 220—233, 1974. The authors referred to 
Work on micelles in aqueous systems, but ultimately settled 
on inverted micelles in organic solvents; in both cases, the 
?uors Were located in the organic phase. 
The disadvantages of these systems included maintaining 
the stability of the dispersion, and maintaining intimate 
contact betWeen the radioactive sample and the ?uor mol 
ecule. In addition, for some of these systems, it Was evident 
that the addition of the aqueous radioactive sample could 
have untoWard effects on the ability of the system to reliable 
quantify the amount of radioactivity in the sample. When the 
?uor molecule Was protected from the samples, as in the 
case of ?laments and modem ?oW-through cells, a distinct 
advantage Was the marked reduction in chemical quenching, 
although optical quenching (self-quenching) Was still a 
potential problem. 
This approach Was ultimately abandoned in favor of the 
alternative approach in Which aqueous samples Were mixed 
or solubiliZed in organic solvents into Which ?uors had been 
dissolved. Initially, this Was accomplished by employing 
secondary solvents that Were miscible With both Water and 
toluene (e.g., alcohols, dioxane). Ultimately, a series of neW 
surfactants Were developed that alloWed the emulsi?cation 
of aqueous samples in organic cocktail solvents in suf?cient 
quantities. This is still the basic technology employed When 
researchers use liquid scintillation counting to quantify the 
amount of radioactivity in aqueous samples. Commercially 
available cocktails may contain combinations of solvents, 
emulsifying agents and primary and secondary ?uors. 
Although Widely used, these cocktails have several short 
comings. Among these are that impurities in aqueous 
samples can lead to signi?cant chemical and optical quench 
ing; this can also occur as a result of the signi?cant quan 
tities of dissolved oxygen frequently found in aqueous 
samples. The emulsifying agents themselves can interact 
US 6,855,270 B2 
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With ?uor molecules resulting in signi?cant quenching; the 
same can occur With solubiliZing agents used to solubiliZe 
certain samples such as tissues or electrophoretic gels. 
Organic solvents and ?oors can interact With plastic scin 
tillation vials producing Wall effects. However, the greatest 
problem involves the disposal of the large quantities of 
“mixed” (radioactive and organic) Waste generated by liquid 
scintillation counting. For example, a 1990 report commis 
sioned by the Nuclear Regulatory Commission and the 
Environment Protection Agency titled “National Pro?le on 
Commercially Generated LoW-Level Radioactive Mixed 
Waste” (NUREG/CR-5938) demonstrated the extent of the 
problem. Based on the report, 140,000 ft3 of mixed Waste 
Was generated by industry and academia in the United States 
in 1990 alone. Of this, approximately 100,000 ft3 or 71% 
Was haZardous organic liquid scintillation ?uid containing 
loW-level long-lived mixed radioactive Waste. 
The most common ?uor molecule used in organic-based 
cocktails is 2,5-diphenyloxaZole (PPO), Which is classi?ed 
as “Water-insoluble”. Further, PPO has the highest quantum 
yield (4), 0.83) of the four primary ?uor molecules shoWn in 
Table 1. For liquid scintillation counting, the optimal con 
centration of PPO dissolved in toluene or xylene is 5—7 
mg/mL. 
TABLE 1 
Characteristics of Scintillators Used in 
Liquid Scintillation Counting 
Optimum Fluorescence 
[Flour] Maximum 
Scintillator mg/mL (nm) 
Primary 
2,5—diphenyloxaZole(PPO) 5-7 375 
2,(4—biphenylyl)—5—phenyl—1,3,4-oxadiazole 8-10 375 
(PBD) 
2-(4-biphenylyl)—5-(4—tert—butylphenyl)—1,3,4— 12 385 
oxadiaole butyl-PBD) 
2,5-bis(5-tert-butyl-2—benzoxazolyl)thiophene 7 446 
(BBOT) 
Secondary 
1,4-bis(5—phenyloxazol—2yl)benZene(POPOP) 0.05—0.2 — 
1,4-bis(2-methylstyryl)benzene(bis-MSB) 1.5 — 
US. Pat. No. 4,588,698 by Gruner et al. teaches the use 
of polyvinyltoluene microspheres containing solid phase 
scintillators that are coated With carbohydrate materials that 
provide a selective permeable coating for radioimmunoas 
say. A speci?c requirement is that the microspheres have a 
diameter of at least 1 micrometer (1000 nanometers), and 
more preferably have a “Width at least as Wide as the range 
of radioactivity of said radiation”. As a result of the selective 
permeable coating and the large siZe of the microspheres, the 
radiation detection system Would be able to detect more 
diffusable loWer molecular Weight compounds With little or 
no interference from less diffusible higher molecular Weight 
compounds. Gruner et al. do not teach the use of nanopar 
ticles containing ?uor molecules made from oil-in-Water 
microemulsion precursors Wherein said nanoparticles have 
diameters less than 100 nanometers and that are permanently 
suspended in an aqueous medium. 
US. Pat. No. 5,512,753 by Thomson et al. describe the 
use of scintillator capsules Wherein a liquid scintillator core 
is encapsulated Within a shell made from a polymer such as 
melamine formaldehyde or polymethyl methacrylate. Thom 
son et al. teach the use of scintillator capsules having 
diameters from 0.1—10,000 micrometers made by 
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“mechanical/physical processes or chemical processes” such 
as spray-coating, pan coating, ?uid-bed coating, and inter 
facial polymeriZation or other chemical techniques that 
occur as an “emulsion or dispersion”. A preferred embodi 
ment of the Thomson et al. invention is that greater than 99% 
of the scintillator core comprises aromatic liquid solvent(s) 
such as toluene or xylene that has dissolved primary ?uor 
molecule in the range of 0.01 to 5.0% W/W and dissolved 
secondary ?uor molecule in the range of 0.001 to 0.5% W/W. 
Thomson et al. do not teach the use of nanoparticles con 
taining solid ?uor molecules made from oil-in-Water micro 
emulsion precursors Wherein said nanoparticles have diam 
eters less than 100 nanometers and that are permanently 
suspended in an aqueous medium. Further, Thomson et al. 
do not teach the use of a system that is free of organic 
solvents. Finally, Thomson et al. do not the teach the use of 
a detection system that may comprise up to 33% W/W ?uor 
molecule 
US. Pat. No. 4,127,499 by Chen et al. describes the use 
of polymeric particles derived from a latex that are coated 
With at least one uniformly dispersed ?uor Wherein said 
latex particles have a diameter no greater than 0.2 microme 
ters. Chen et al. teaches the use of “substantially dry” 
systems Wherein at least 80% by Weight of Water has been 
removed. Chen et al. further teach a method of preparing the 
?uor-coated latex particles by adding ?uor molecule dis 
solved in a Water-miscible solvent to latex particles With 
subsequent addition of Water to force the ?uor molecules 
into or onto the latex particles. Chen et al. further teach a 
method of coating the prepared system onto a solid support 
such as paper or ?lm. Chen et al. do not teach the use of 
nanoparticles containing ?uor molecules made from oil-in 
Water microemulsion precursors Wherein said nanoparticles 
have diameters less than 100 nanometers and that are 
permanently suspended in an aqueous medium. Chen et al. 
further do not teach the use of nanoparticles containing high 
concentrations of ?uor molecules that are formed in a 
one-step process and immediately useable. 
US. Pat. No. 5,250,236 by Gasco describes the use of 
solid lipid microspheres that are formed by diluting one 
volume of the mixture of molten lipid substance, Water, 
surfactant and possibly a co-surfactant to 100 volumes of 
cold Water. Gasco teaches the preparation of microspheres 
smaller than one micrometer and in particular betWeen 
50—800 nanometers, and preferably betWeen 100 and 400 
nanometers. Gasco also teaches the preparation of micro 
spheres Wherein said solid lipid microspheres may contain a 
pharmacologically active substance, such as a drug. Gasco 
does not teach the use of nanoparticles containing ?uor 
molecules made from oil-in-Water microemulsion precur 
sors Wherein said nanoparticles are formed from oil-in-Water 
microemulsions directly by cooling or by polymeriZation 
With no dilution of the most useful system. 
As illustrated, the references described above appear to 
lack preferred compositions and properties for an effective 
and useful system to detect beta-particle emitting radioiso 
topes. Namely, the references do not describe or teach the 
use of oil-in-Water microemulsion precursors Wherein the 
oil-phase of the microemulsion contains high concentrations 
of ?uor molecules; Wherein said oil-in-Water microemul 
sions are subsequently treated, or cured, to produce stable, 
permanently suspended nanoparticles having diameters less 
than 1000 nanometers, or even less than 100 nanometers. 
These useful nanoscintillation systems can be engineered in 
a one-step process and used to detect beta-particle emitting 
radioisotopes. 
SUMMARY OF THE INVENTION 
In one respect, the invention involves a nanoscintillation 
system including nanoparticles suspended in an aqueous 
US 6,855,270 B2 
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vehicle. The nanoparticles include: at least one nanoparticle 
matrix material, at least one surfactant or co-surfactant or a 
mixture thereof, and at least one primary or secondary ?uor 
molecule or a mixture thereof. The nanoparticles can have a 
diameter less than 300 nanometers. The nanoparticles can 
have a diameter less than 100 nanometers. The nanoscintil 
lation system can also include an electron-emitting or alpha 
particle-emitting radioisotope. The electron-emitting or 
alpha-particle-emitting radioisotope can be free or attached 
to one or more molecules in the aqueous vehicle. The 
nanoscintillation system can also include one or more 
ligands coupled to one or more of the nanoparticles. The one 
or more ligands can include a protein, carbohydrate, or a 
combination thereof. The nanoparticle matrix material can 
include emulsifying Wax, a polyoxyethylene sorbitan fatty 
acid ester, a polyoxyethylene alkyl ether, a polyoxyethylene 
stearate, or polystyrene or its derivative or copolymer 
thereof. The nanoparticle matrix material can be present at 
a concentration from 0.1 to 300 mg/mL. The aqueous 
vehicle can include Water or an aqueous buffer. The surfac 
tant or co-surfactant can include a polyoxyethylene alkyl 
ether, a polyoxyethylene sorbitan fatty acid ester, a poly 
oxyethylene stearate, an alkoxylated alcohol or its derivative 
thereof, or an alcohol. The surfactants can be present at a 
total concentration of 1—5000 mM. The primary ?uor mol 
ecule can include 2,5-diphenyloxaZole (PPO), 2-(4 
biphenylyl)-5-phenyl-1,3,4-oxadiaZole (PBD), 2-(4 
biphenylyl)-5-(4-tert-butylphenyl)-I,3,4-oxadiaZole (butyl 
PBD), 2,5-bis(5-tert-butyl-2-benZoxaZolyl)thiophene 
(BBOT), or derivatives or combinations thereof. The sec 
ondary ?uor molecule can include 1,4-bis(5-phenyloxaZol 
2yl)benZene (POPOP), 1,4-bis(2-methylstyryl)benZene (bis 
MSB), or derivatives or combinations thereof. The primary 
?uor molecules can be present at a total concentration of at 
least 1 mg/mL. Water can be at least 50% of the total Weight 
of the nanoscintillation system. 
In another respect, the invention involves a method for 
scintillation measurement. A nanoscintillation system as 
described above (a nanoscintillation system including nano 
particles suspended in an aqueous vehicle, the nanoparticles 
including: at least one nanoparticle matrix material, at least 
one surfactant or co-surfactant or a mixture thereof, and at 
least one primary or secondary ?uor molecule or a mixture 
thereof) is obtained, and scintillation associated With the 
nanoscintillation system is measured. 
In another respect, the invention involves a nanoparticle 
including: at least one nanoparticle matrix material, at least 
one surfactant or co-surfactant or a mixture thereof, and at 
least one primary or secondary ?uor molecule or a mixture 
thereof, Wherein the nanoparticle is made from an oil-in 
Water microemulsion precursor. The nanoparticle can be 
made by cooling the oil-in-Water microemulsion to room 
temperature While stirring. The nanoparticle can include an 
emulsifying Wax, a polyoxyethylene sorbitan fatty acid 
ester, a polyoxyethylene alkyl ether, a polyoxyethylene 
stearate, polystyrene, or derivatives or combinations thereof. 
The nanoparticle can include polystyrene, a copolymer of 
polystyrene, or a derivative thereof and having a melting 
point betWeen 40° C. and 80° C. The nanoparticle can 
include styrene, divinyl benZene, toluene, an aromatic or 
unsaturated monomer capable of being polymeriZed by one 
or more free radicals, or a derivative or combination thereof. 
The nanoparticle can be present at a concentration from 0.1 
to 300 mg/mL. The surfactant or co-surfactant can include a 
polyoxyethylene alkyl ether, a polyoxyethylene sorbitan 
fatty acid ester, a polyoxyethylene stearate, an alkoxylated 
alcohol or its derivative thereof, or an alcohol. The surfac 
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tants can be present at a total concentration of 1—5000 mM. 
The surfactants can be present at a total concentration of 
1—300 mM. The primary ?uor molecule can include 2,5 
diphenyloxaZole (PPO), 2-(4-biphenylyl)-5-phenyl-1,3,4 
oxadiaZole (PBD), 2-(4-biphenylyl)-5-(4-tert-butylphenyl) 
1,3,4-oxadiaZole (butyl-PBD), 2,5-bis(5-tert-butyl-2 
benZoxaZolyl)thiophene (BBOT), or derivatives or 
combinations thereof. The secondary ?uor molecule can 
include 1,4-bis(5-phenyloxaZol-2yl)benZene (POPOP), 1,4 
bis(2-methylstyryl)benZene (bis-MSB), or derivates or com 
binations thereof. The primary ?uor molecules can be 
present at a total concentration of at least 1 mg/mL. The 
nanoparticle can be made by polymeriZing the nanoparticle 
matrix material Within the oil-in-Water microemulsion pre 
cursor by free-radical polymeriZation. Free-radical polymer 
iZation can be performed by heating the oil-in-Water micro 
emulsion precursor, by adding a free-radical initiator, or by 
a combination thereof. 
In another respect, the invention involves a method for 
scintillation measurement, in Which a nanoparticle as 
described above (a nanoparticle including: at least one 
nanoparticle matrix material, at least one surfactant or 
co-surfactant or a mixture thereof, and at least one primary 
or secondary ?uor molecule or a mixture thereof, Wherein 
the nanoparticle is made from an oil-in-Water microemulsion 
precursor) is obtained, and scintillation associated With the 
nanoparticle is measured. 
In another respect, the invention involves a method of 
making a nanoscintillation system. A liquid nanoparticle 
matrix material is dispersed With a ?uor molecule in an 
aqueous continuous phase to form a surfactant stabiliZed 
microemulsion. The surfactant stabilized microemulsion is 
cooled to room temperature While stirring. 
In another respect, the invention involves a method of 
making a nanoparticle useful for scintillation. Ananoparticle 
matrix material is obtained. The nanoparticle matrix mate 
rial is melted to form a liquid dispersed phase. A ?uor 
molecule is dispersed into the liquid dispersed phase. The 
the liquid dispersed phase is dispersed, including the ?uor 
molecule, in an aqueous continuous phase to form a surfac 
tant stabiliZed microemulsion. The microemulsion is cooled 
While stirring to form a solid stable nanoparticle having a 
diameter of less than about 300 nanometers, Which includes 
the ?uor molecule either entrapped in or adsorbed to the 
nanoparticle. The melting can occur at a temperature 
betWeen about 35° C. and about 100° C. The cooling can 
include cooling With no dilution in Water. 
In another respect, the invention involves a method of 
making a nanoscintillation system. A liquid nanoparticle 
matrix material is dispersed With a ?uor molecule in an 
aqueous continuous phase to form a surfactant stabiliZed 
microemulsion, and the liquid nanoparticle matrix material 
is polymeriZed by free-radical polymeriZation. The free 
radical polymeriZation can be performed by heating the 
surfactant stabiliZed microemulsion, by adding a free-radical 
initiator, or by a combination thereof. The method can also 
include concentrating the nanoscintillation system. The con 
centrating step can include comprising centrifugal ultra?l 
tration. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 Particle siZe of cured nanoparticles made from 
oil-in-Water microemulsion precursors as a function of the 
?nal concentration of polymeric surfactant used in the 
process. 
FIG. 2 The effect of three different curing methods of 
oil-in-Water microemulsion precursors on the resulting par 
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ticle size of polyoxyethylene 2 stearyl ether nanoparticles. 
Polyoxyethylene 2 stearyl ether is sold under the trademark 
Brij 72. Method A) cooling of the undiluted oil-in-Water 
microemulsion at 55° C. to room temperature While stirring, 
Method B) cooling of the oil-in-Water microemulsion at 55° 
C. by placing undiluted in a refrigerator at 4° C., and Method 
C) diluting (1/10) the oil-in-Water microemulsion at 55° C. 
With Water at 4° C. 
FIG. 3 The effect of three different curing methods of 
oil-in-Water microemulsion precursors on the resulting par 
ticle siZe of Emulsifying Wax nanoparticles. Method A) 
cooling of the undiluted oil-in-Water microemulsion at 55° 
C. to room temperature While stirring, Method B) cooling of 
the oil-in-Water microemulsion at 55° C. by placing undi 
luted in a refrigerator at 4° C., and Method C) diluting (1/ 10) 
the oil-in-Water microemulsion at 55° C. With Water at 4° C. 
FIG. 4 Particle siZe of cured nanoscintillation systems 
made from oil-in-Water microemulsion precursors as a func 
tion of the ?nal concentration of PPO (2,5 -diphenyloxaZole) 
in Water. For all preparations, the ratio of nanoparticle 
matrix material to PPO Was 2:1 W/W. 
FIG. 5 Particle siZe of cured solid nanoparticles coated 
With different amounts of a ligand, asialofetuin-palmitate 
(ASF-pal). 
FIG. 6 The effect of nanoparticle concentration on the 
counting ef?ciency of a nanoscintillation system. 
DETAILED DESCRIPTION OF THE 
INVENTION 
This invention relates to the engineering of nanoparticles, 
containing ?uor molecules, that are permanently suspended 
in aqueous-based media and used to detect either electron 
emitting isotopes or alpha-particle emitting radioisotopes. 
Electron emitting isotopes (e.g., 3H and 14C) or alpha 
particle emitting isotopes in samples generated during 
experiments are typically aqueous in nature and must be 
mixed With an organic solvent containing ?uor molecules 
(scintillators) to form an emulsion-based cocktail. The most 
ef?cient ?uor molecules have very loW Water solubilities, 
necessitating the use of organic solvents such as toluene or 
xylene. Although very ef?cient at quantifying radioactivity 
in the samples, there are several problems associated With 
this technology. The amount of an aqueous sample that can 
be added to a cocktail solution is ?nite and may be a limiting 
factor With regard to sensitivity. In addition, after they are 
used, radioactive organic cocktails present a signi?cant 
Waste disposal problem in terms of cost and environmental 
haZards. The development of an aqueous-based scintillation 
cocktail Would provide tremendous scienti?c, economical 
and environmental advantages over the traditionally used 
organic-based cocktails. 
The very small particle siZe of the nanoscintillation 
systems, or nanoparticles less than 100 nanometers contain 
ing ?uor molecules, Would theoretically aid in the detection 
ef?ciency of the most commonly used [3' particles, 3H and 
14C. For example, [3- particles are observed to have uniform, 
loW speci?c ioniZation (oE/ox) except at the end of its path. 
The range of a 10 keV [3' particle in Water is estimated to be 
2.5 pm (Horrocks, D. L. In: Applications of Liquid Scintil 
lation Counting. Academic Press. NeW York. p. 16, 1964). If 
nanoparticles With an average diameter of 50 nm are dis 
persed in an aqueous solution at a concentration of 2 mg/mL, 
then it can be calculated that the average distance betWeen 
particles in that solution is 0.32 pm. Thus, it is expected that 
[3' particles emitted from 3H and 14C that are uniformly 
distributed in this nanoparticle suspension Will have a high 
probability of interacting With a ?uor molecule. 
10 
15 
25 
35 
40 
45 
55 
65 
8 
This invention also relates to the use of oil-in-Water 
microemulsions as precursors to engineer solid nanopar 
ticles containing ?uor molecules. It Was discovered that very 
poorly Water soluble drugs could be easily solubiliZed in the 
oil-phase of the microemulsion precursor and subsequently 
entrapped in nanoparticles engineered from said microemul 
sion precursors. For example, it Was discovered that the 
solubility of Gadolinium acetylacetonate (GdAcAc), a 
potential anti-cancer agent, in Water could effectively be 
increased by at least 4000-fold using the methods described 
in this invention. Speci?cally, the solubility of GdAcAc is 
only 1 mg per 2000 mL Water HoWever, utiliZing the said 
methods described in this invention to entrap GdAcAc in 
stable nanoparticles having diameters of about 50 
nanometers, only 1 milliliter of Water is required to solubi 
liZe 2 mg GdAcAc. It Was hypothesiZed that said methods 
could be applied to solubiliZe ?uor (scintillator) molecules 
knoWn to have very limited or no aqueous solubility, and 
thus, eliminate the need for organic solvent-based liquid 
scintillation cocktails. 
An additional advantage of this invention over existing 
technology is that the described nanoscintillation systems 
can be engineered rapidly, reproducibly, and cost-effectively 
in a one-step process contained in one manufacturing vessel, 
vial, or container. 
As used herein, certain terms may have the folloWing 
de?ned meanings. 
As used in the speci?cations and claims, the singular form 
a, an, and the include plural references unless the context 
clearly dictates otherWise. For example, the term a nano 
particle may refer to one more nanoparticles for use in the 
presently disclosed systems. 
As used herein, the term “solubility” refers to the extent 
to Which a solute is dissolved in a solvent. Solubility can be 
described in terms such as described in REMINGTON’S 
PHARMACEUTICAL SCIENCES ranging from very 
soluble (less than 1 part of solvent per 1 part of solute) to 
insoluble (more than 10,000 parts of solvent for 1 part of 
solute). The term “Water-insoluble” refers to a substance or 
solute Where more than 10,000 parts of Water are needed to 
dissolve 1 part of solute. 
The term “nanoparticle” refers to particles have diameters 
beloW 1 micrometer in diameter that are comprised of 
primarily one solid phase. “Stable nanoparticles” remain 
largely unaffected by environmental factors such as 
temperature, pH, body ?uids, or body tissues. HoWever, 
solid nanoparticles may be designed to respond to these 
environmental factors in a controlled and predictable man 
ner. The solid nanoparticles may contain many different 
materials for various pharmaceutical and engineering appli 
cations such as plasmid DNA for gene therapy and genetic 
vaccines, peptides and proteins or small drug molecules, 
magnetic substances for use as nanomagnets, lubricants, or 
chemical, thermal, or biological sensors. It is also envi 
sioned that ?uor molecules may be entrapped or coated on 
any submicron particle, including but not limited to the 
folloWing, liposome, micelle, polymeric nanoparticle, pre 
cipitated particle, or particles formed by radiation, free 
radical polymeriZation, milling, homogeniZation, or microf 
luidiZation. 
As used herein, the term “nanoparticle matrix material” 
refers to those materials that can form both the shell and 
majority of the Weight composition of the said nanoparticle. 
TWo types of matrix materials are envisioned, both serving 
as the oil-phase in the oil-in-Water microemulsion precursor. 
The ?rst matrix materials are those materials that are amphi 
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pathic in nature (having both hydrophilic and hydrophobic 
moieties), are primarily Water-insoluble, and that melt above 
room temperature in the range of 30—100° C., more prefer 
ably in the range of 40—90° C., and most preferably in the 
range of 40° C.—80° C. It is envisioned that these materials 
can be any substance meeting the above criteria and that are 
a Wax, lipid, polymeric surfactant, or combinations thereof. 
It is most preferred, but not absolutely required, that these 
materials are selected from the folloWing; emulsifying Wax, 
polyoxyethylene sorbitan fatty acid esters, polyoxyethylene 
alkyl ethers, polyoxyethylene stearates, or loW molecular 
Weight polystyrene, polyvinyltoluene, or its derivatives or 
copolymers of aromatic polymers thereof. The second 
matrix materials are those materials that are liquids at room 
temperature (i.e., <30° C.), and that can become a solid by 
free-radical polymeriZation from Within the oil-phase of the 
oil-in-Water microemulsion; Wherein said polymeriZation 
process may be induced by any method including, but not 
limited to, heat, change in temperature, light, ultraviolet 
radiation, free-radical initiators, or combinations thereof. It 
is most preferred, but not absolutely required, that these 
materials are selected from the folloWing; styrene, divinyl 
benZene, toluene, or their derivatives or combinations 
thereof. 
As used herein, the term “permanently suspended” refers 
to nanoparticles, engineered from said oil-in-Water micro 
emulsion precursors, that remain suspended in aqueous 
media such as Water or buffer for at least one month at room 
temperature and that cannot be settled by ultracentrifugation 
treatment at 50,000 cpm for 5 minutes. 
As used herein, the term “ligand” refers to those sub 
stances that be recognized and bind to a speci?c molecule, 
a cell-receptor, an antibody, an anti-antibody, or combina 
tions thereof. It is preferred that the ligand be comprised of 
carbohydrates or amino acids or combinations thereof. It is 
most preferred that the ligand be a monoclonal or polyclonal 
antibody. The ligand may be attached onto said nanopar 
ticles by any number of processes including, but not limited 
to, covalent attachment, ionic interaction, hydrophobic 
interaction, and hydrogen bonding. It is also envisioned that 
the ligand may be chemically modi?ed to enhance the 
attachment of said ligand to said nanoparticle to either 
increase the ef?ciency of detection or selectively detecting 
one or more radioactive molecules from other molecules. 
As used herein, a “microemulsion” is a stable biphasic 
mixture of tWo immiscible liquids stabiliZed by a surfactant 
and usually a co-surfactant. Microemulsions are thermody 
namically stable, isotropically clear, form spontaneously 
Without excessive mixing, and have dispersed droplets in the 
range of 5 nm to 140 nm. In contrast, emulsions are opaque 
mixtures of tWo immiscible liquids. Emulsions are thermo 
dynamically unstable systems are usually require the appli 
cation of high-torque mechanical mixing or homogeniZation 
to produce dispersed droplets in the range of 0.2 to 25 pm. 
Both microemulsions and emulsions can be made as Water 
in-oil or oil-in-Water systems. Whether Water-in-oil or oil 
in-Water systems Will form is largely in?uenced by the 
properties of the surfactant. The use of surfactants that have 
hydrophilic-lipophilic balances (HLB) of 3—6 tend to pro 
mote the formation of Water-in-oil microemulsions While 
those With HLB values of 8—18 tend to promote the forma 
tion of oil-in-Water microemulsions. 
Microemulsions Were ?rst described by Hoar and Schul 
man in 1943 after they observed that a medium chain alcohol 
could be added to an emulsion to produce a clear system 
Within a de?ned ‘Window’, noW referred to as a microemul 
sion WindoW. Aunique physical aspect of microemulsions is 
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the very loW interfacial surface tension (y) betWeen the 
dispersed and continuous phases. In a microemulsion, the 
small siZe of the dispersed droplets present a very large 
interface. A thermodynamically stable microemulsion can 
only be made if the interfacial surface tension is loW enough 
so that the positive interfacial energy (YA, Where A equals 
the interfacial area) can be balanced by the negative free 
energy of mixing (AG,,). The limiting y value needed to 
produce a stable microemulsion With a dispersed droplet of 
10 nm, for example, can be calculated as folloWs: AGm=— 
TASm (Where T is the temperature and the entropy of mixing 
AS,” is of the order of the BoltZman constant KB). Thus, 
KBT=4rcr2y and the limiting y value is calculated to be 
KBT/4J'cr2 or 0.03 mM m_1. Often, a co-surfactant is required 
in addition to the surfactant to achieve this limiting interfa 
cial surface tension. 
In addition to their unique properties as mentioned above, 
microemulsions have several key advantages for use as 
delivery systems intended for use in marketed pharmaceu 
tical products, namely; i) increased solubility and stability of 
drugs incorporated into the dispersed phase, ii) increased 
absorption of drugs across biological membranes, iii) ease 
and economy of scale-up (since expensive mixing equip 
ment is often not needed), and iv) rapid assessment of the 
physical stability of the microemulsion (due to the inherent 
clarity of the system). For example, oil-in-Water microemul 
sions have been used to increase the solubility of lipophilic 
drugs into formulations that are primarily aqueous-based 
(Constantinides, P. P. Lipid microemulsions for improving 
drug dissolution and oral absorption: physical and biophar 
maceutical aspects. Pharm. Res. 12:1561—1572, 1995). Both 
oil-in-Water and Water-in-oil microemulsions have been also 
been shoWn to enhance the oral bioavailability of drugs 
including peptides (Bhargava, H. N., Narurkar, A. Lieb, L. 
M. Using microemulsions for drug delivery. Pharm. Tech. 
March 46—53, 1987; Ho H. O., Hsiao, C. C., Sheu, M. T. 
Preparation of microemulsions using polyglycerol fatty acid 
esters as surfactant for the delivery of protein drugs. J. 
Pharm. Sci. 85:138—143, 1996; Constantinides, P. P. Lipid 
microemulsions for improving drug dissolution and oral 
absorption: physical and biopharmaceutical aspects. Pharm. 
Res. 12:1561—1572, 1995). 
Although microemulsions have many potential advan 
tages they do have potential limitations, namely; a) they are 
complex systems and often require more development time, 
b) a large number of the proposed surfactants/co-surfactants 
are not pharmaceutically acceptable (Constantinides, P. P. 
Lipid microemulsions for improving drug dissolution and 
oral absorption: physical and biopharmaceutical aspects. 
Pharm. Res. 12:1561—1572, 1995), c) the microemulsions 
are not stable in biological ?uids due to phase inversion. 
Thus, the microemulsions themselves are not effective in 
delivering drugs intracellularly or targeting drugs to differ 
ent cells in the body. The development of a microemulsion 
involves the very careful selection and titration of the 
dispersed phase, the continuous phase, the surfactant and the 
co-surfactant. Time consuming pseudo-phase ternary dia 
grams involving the preparation of a large number of 
samples must be generated to ?nd the existence of the 
‘microemulsion WindoW’, if any. In general, a Water-in-oil 
microemulsion is typically much easier to prepare than an 
oil-in-Water microemulsion. The former system is useful for 
formulating Water-soluble peptides and proteins to increase 
their stability and absorption While the later system is 
preferred for formulating drugs With little or no aqueous 
solubility. 
Used herein a “surfactant” refers to a surface-active agent, 
including substances commonly referred to as Wetting 
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agents, detergents, dispersing agents, or emulsifying agents. 
For the purposes of this invention, it is preferred that the 
surfactant has an HLB value of 6—20, and most preferred 
that the surfactant has an HLB value of 8—18. It is preferred, 
but not required, that the surfactant is selected from the 
folloWing groups; polyoxyethylene alkyl ethers, polyoxy 
ethylene sorbitan fatty acid esters, polyoxyethylene 
stearates, alkoxylated alcohols sold under the trademark 
TRITON or its derivatives thereof, or an alcohol. It is also 
most preferred that the surfactant has an HLB value of 8—18 
and has an aromatic moiety such as found in octylphenol 
ethoxylates sold under the trademark TRITON X-100 or 
alkoxylates sold under the trademark TRITON N-57 
(n-Alkyl phenyl polyethylene oxide; HLB=10). A “co 
surfactant” refers to a surface-active agent, including sub 
stances commonly referred to as Wetting agents, detergents, 
dispersing agents, or emulsifying agents. It is preferred, but 
not required, that the co-surfactant is selected from the 
folloWing groups; polyoxyethylene alkyl ethers, polyoxy 
ethylene sorbitan fatty acid esters, polyoxyethylene 
stearates, or alkoxylated alcohols sold under the trademark 
TRITON or its derivatives thereof. It is most preferred that 
the co-surfactants are short-chained alcohols such as 
1-butanol, 2-pentanol, and 1-phenoxyethanol, or combina 
tions thereof. It is also preferred that the total concentration 
of surfactant and/or co-surfactant present in both the oil-in 
Water microemulsion precursor and the nanoscintillation 
system is in the range of 1—5000 mM, more preferably in the 
range of 1—1000 mM, and most preferably in the range of 
1—300 mM. It is envisioned that any surfactant, 
co-surfactant, or combination thereof, that promotes the 
formation of a oil-in-Water microemulsion may be useful for 
this invention. 
The groWing interest in nanotechnology has also resulted 
in the use of microemulsions as precursors or templates to 
form nanoparticles Within the small dispersed droplets (Li, 
Y., Park, C. W. Particle siZe distribution in the synthesis of 
nanoparticles using microemulsions, Langmuir, 15: 
952—956, 1999; Cavalli, R., Peira, E., Caputo, O., Gasco, M. 
R. Solid lipid nanoparticles as carriers of hydrocortisone and 
progesterone complexes With cyclodextrins, International 
Journal of Pharmaceutics, 182:59—69, 1999; Bocca, C., 
Caputo, O., Cavalli, R., Gabriel, L., Miglietta,A., Gasco, M. 
R. Phagocytic uptake of ?uorescent stealth and non-stealth 
solid lipid nanoparticles, International Journal of 
Pharmaceutics, 175: 185—193, 1998; Tojo, C., Blanco, M. 
C., LopeZ-Ouintela, M. A. In?uence of reactant excess and 
?lm ?exibility on the mechanism of nanoparticle formation 
in microemulsions: A Monte Carlo simulation, Langmuir, 
14:6835—6839, 1998; Munshi, N., De, T. K., Maitra, A. 
Preparation and siZe modulation of drug loaded nanoencap 
sulated particles using microemulsion mediated method, 
Journal of Controlled Release, 41:S7, 1997; Ruys, A. J., 
Mai, Y. W. The nanoparticle-coating process: a potential 
sol-gel route to homogeneous nanocomposites, Materials 
Science and Engineering 265:202—207, 1999). These reports 
have primarily dealt With the preparation of Water-in-oil 
microemulsions (Lade, M., Mays, H., Schmidt, J., 
Willumeit, R., Schomacker, R. On the nanoparticle synthesis 
in microemulsions: detailed characteriZation of an applied 
reaction mixture, Colloids and Surfaces A: Physicochemical 
and Engineering Aspects, 163:3—15, 2000; Song, K. C., 
Kang, Y. Preparation of high surface area tin oxide poWders 
by a homogeneous precipitation method, Materials Letters, 
42:283—289, 2000; Porta, E, Bifulco, C., Fermo, P., Bianchi, 
C. L., Fadoni, M., Prati, L. Synthesis of spherical nanopar 
ticles of Cu2L205 (L=Ho, Er) from W/O microemulsions, 
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Colloids and Surfaces A: Physicochemical and Engineering 
Aspects, 160:281—290, 1999) Whereby nanoparticles are 
formed in the Water phase by the use of photochemistry 
(Agostiano, A., Catalano, M., Curri, M. L., Della Monica, 
M., Manna, L., Vasanelli, L. Synthesis and structural char 
acteriZation of CdS nanoparticles prepared in a four 
components “Water-in-oil” microemulsion, Micron, 
31:253—258, 2000), y-rays (Xiangling, X., XueWu, G., 
Qiang, Y., Zhicheng, Z., Ju, Z., AiZhen, N., ManWei, Z. 
GroWth of polymer nanoparticles in microemulsion poly 
meriZation initiated With ray, Radiation Physics and 
Chemistry, 54: 279—283, 1999), or electrochemistry (Tang, 
Z., Liu, S., Wang, Z., Dong, S., Wang, E. Electrochemical 
synthesis of polyaniline nanoparticles, Electrochemistry 
Communications, 2:32—35, 2000) to induce crosslinking, 
polymeriZation (Fang, J ., Stokes, K. L., Wiemann, J ., Zhou, 
W. Nanocrystalline bismuth synthesiZed via an in situ poly 
meriZation microemulsion process, Materials Letters, 
42:113—120, 2000; Capek, I. Microemulsion polymeriZation 
of styrene in the presence of anionic emulsi?er, Advances in 
Colloid and Interface Science, 82: 253—273, 1999: Meier, W. 
Nanostructure synthesis using surfactants and copolymers, 
Current Opinion in Colloid & Interface Science, 4:6—14, 
1999) and/or complexation of the appropriate agents in the 
Water phase. 
As used herein, the term “microemulsion precursor” 
refers to an oil-in-Water microemulsion Wherein the oil 
phase droplets serves a precursor, or template, to form solid 
nanoparticles after subjecting said microemulsion to a cur 
ing process. The “curing” process or method involves either 
the direct cooling of the said microemulsion to room tem 
perature Without dilution, or by free-radical polymerization 
induced by heat or the inclusion of a free-radical initiator, or 
combinations thereof. 
As used herein, the term “nanoscintillation” system refers 
to solid nanoparticles suspended in an aqueous vehicle 
Wherein said nanoparticles are comprised of a nanoparticle 
matrix material, at least one surfactant or co-surfactant or a 
mixture thereof, and at least one primary or secondary ?uor 
molecule or a mixture thereof. It is preferred that the 
nanoparticles have a diameter of less than 1000 nanometers 
and are present in the system at a concentration from 
0.1—500 mg/mL, even more preferably that the nanoparticles 
have a diameter of less than 300 nanometers and are present 
in the system at a concentration from 0.1—300 mg/mL. It is 
most preferred that the nanoparticles have a diameter of less 
than 100 nanometers and are present in the system at a 
concentration from 0.1—10 mg/mL. It is also envisioned that 
?uor molecules may be entrapped or coated on any submi 
cron particle, including but not limited to the folloWing, 
liposome, micelle, polymeric nanoparticle, precipitated 
particle, or particles formed by radiation, free-radical 
polymeriZation, milling, homogeniZation, or micro?uidiZa 
tion. Nanoscintillation systems may be used to detect an 
electron-emitting or alpha-particle emitting radioisotope or 
radioisotopes, free or attached to a molecule or molecules in 
an aqueous vehicle. Further, it is envisioned that said nanos 
cintillation systems may be used as detection systems in 
chromatographic analytical methods such as any type of 
liquid chromatography (LC) or in scintillation proximity 
assays (SPAs) or in radioimmuno assays (RIAs). It is further 
envisioned that any type of electron may be detected such as, 
but not limited to, beta-particles, Auger electrons, and inter 
nal conversion electrons. 
As used herein, “?uor” molecules , or scintillators, refer 
to organic molecules that may be excited by energy to 
become ?uorescent and emit photons. Fluor molecules that 
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directly absorb the excitation of energy of the solvent are 
known as “primary ?uor” molecules. “Secondary ?uor” 
molecules are often added to amplify the primary emissions. 
The use of a secondary ?uor molecule often results in greatly 
improved detection ef?ciency. For this invention, it is 
preferred, but not required that the primary ?uor molecules 
are selected from the following; 2,5 -diphenyloxaZole (PPO), 
2-(4-biphenylyl)-5-phenyl-1,3,4-oxadiaZole (PBD), 2-(4 
biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiaZole (butyl 
PBD), or 2,5-bis(5-tert-butyl-2-benZoxaZolyl)thiophene 
(BBOT), or combinations thereof. For this invention, it is 
preferred, but not required that the secondary ?uor mol 
ecules are selected from the following; 1,4-bis(5 
phenyloxaZol-2yl)benZene (POPOP) or derivatives thereof, 
or 1,4-bis(2-methylstyryl)benZene (bis-MSB), or combina 
tions thereof. 
Nanoscintillation systems can be evaluated by many 
methods including the folloWing three measurements: (1) 
the Figure of Merit, (2) the Phase Contact factor and (3) the 
Quench Resistance factor. The Figure of Merit (FOM) Will 
be determined using the folloWing equation: 
Where E=Counting E?iciency=cpm/dpm 
V=Sample Volume 
B=Background 
Counting Efficiency can be determined by adding a 
knoWn amount of radioactivity (dpm) (such as 14C-acetic 
acid or 3H-acetic acid in phosphate buffer, pH 7) to nanos 
cintillation systems and measuring the number of counts 
(cpm) detected. No automatic quench correction parameter 
has to be employed. 
The Phase Contact (PC) factor can be determined using 
the folloWing equation: 
Where Ec=the ef?ciency of counting in a homogenous 
system. 
Radiolabeled benZoic acid can be used since benZoic acid 
has measurable solubility in both Water and toluene. A 
knoWn amount of 14C-benZoic acid can be added to a 
nanoscintillation suspension, and the detection ef?ciency c  be measured. The same amount of 14C-benZoi  acid can 
be added to a high-purity toluene solution into Which has 
been dissolved an identical amount of nanoparticles that 
exist in the nanoscintillation suspension. The detection ef? 
ciency of this system, Which can contain the same amount of 
?uor exists in the nanoscintillation suspension, is the EC 
Which can then be used to calculate the PC factor. The E 
value obtained With the nanoscintillation suspension can be 
compared to the ef?ciency of detection obtained from a 
sample containing the same amount of 14C-b6I1ZO1C acid 
added to the commercially-available Scintiverse BD cock 
tail. 
Quench Resistance (QR) can be determined by the serial 
addition of a quenching agent (e.g., NaCl) to nanoscintilla 
tion Systems containing a ?xed amount of 14C- or 
3H-labeled acetic acid. Counting Efficiency Will be 
plotted as a function of quenching agent added; the QR 
factor is de?ned as the slope of that line. The loWer the 
absolute value of the slope, the greater the quench resis 
tance. This value can be compared to the QR factor mea 
sured for standard cocktails, such as ScintiVerse cocktail. 
The Scintiverse cocktail contains the folloWing ingredients: 
1O 
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2,5-diphenyl-oxaZole (PPO; 0.37% W/W), dioctyl sodium 
sulfosuccinate (13% W/W), disteaZyl pentaerythritol diphos 
phite (0.03% W/W), ethylene oxide-nonylphenol polymer 
(3.4% W/W), 1,4-bis2-(2-methylphenyl)ethenyl-benZene 
(0.08% W/W), and C10—13-alkyl derivatives of benZene 
(82.8% W/W). 
EXAMPLES 
The folloWing examples are included to demonstrate 
speci?c, non-limiting embodiments of this disclosure. It 
should be appreciated by those of skill in the art that the 
techniques disclosed in the examples that folloW represent 
techniques discovered by the inventors to function Well in 
the practice of the invention, and thus can be considered to 
constitute speci?c modes for its practice. HoWever, those of 
skill in the art should, in light of the present disclosure, 
appreciate that many changes can be made in the speci?c 
embodiments Which are disclosed and still obtain a like or 
similar result Without departing from the spirit and scope of 
the invention. 
Example 1 
To determine the existence of an oil-in-Water microemul 
sion WindoW for the microemulsion precursor, exactly tWo 
(2) milligrams of emulsifying Wax Were Weighed accurately 
into ten separate 7-mL glass vials and melted at 50° C. on a 
temperature calibrated magnetic hot plate. Water (0.2 pm 
?ltered) Was then added (750—1000 ML) to form a homoge 
neous milky slurry in the stirring Water at 50° C. To form the 
microemulsion precursor, the surfactant polyoxy 20 stearyl 
ether (100 mM) in Water Was added (0—250 ML) so that the 
?nal surfactant concentration ranged from 0 mM to 25 mM 
in the ten vials. The microemulsion precursor Was then 
removed from heat (52—54° C.) and alloWed to cool to 25° 
C. While stirring. When cooled, visual inspection shoWed 
that systems With ?nal surfactant concentration less than 2.5 
mM Were precipitated, systems With ?nal surfactant con 
centration betWeen 2.5 mM and 10 mM Were either very 
slightly turbid or clear, and systems With a ?nal surfactant 
concentration greater than 10 mM Were either very turbid or 
precipitated. Thus, an apparent microemulsion WindoW Was 
de?ned. One hundred (100) ML of each cooled system Was 
taken and diluted With 900 ML Water. The particle siZe of the 
diluted solid nanoparticles Was determined using a Coulter 
N4 Plus Sub-Micron Particle SiZer at 20° C. by scattering 
light at 90° for 120 seconds. The particle siZes of the cured 
solid nanoparticles as a function of surfactant concentration 
are shoWn in FIG. 1. The particle siZes of systems With no 
surfactant added could not be determined since the systems 
contained precipitates that Were greater than 3000 nm in 
diameter. In general, the particle siZe results agreed With the 
visual observations and suggested the folloWing; 1) solid 
nanoparticles less than 100 nm could be engineered from the 
liquid matrix oil-in-Water microemulsion precursor, and 2) 
the resulting clarity and particle siZe Were related to the ?nal 
concentration of the surfactant used. The droplet siZe of the 
oil phase in the microemulsion nanotemplates made With a 
?nal surfactant concentration of 10 mM Was measured at 55° 
C. and Was found to be 1113 nm demonstrating that oil-in 
Water microemulsion precursor could be made. To determine 
if the measured droplet siZes in either the microemulsion 
nanotemplate or the cured solid nanoparticles Were due to 
the presence of surfactant micelles, samples Were made as 
described above With no emulsifying Wax and With ?nal 
surfactant concentrations ranging from 0 mM to 100 mM in 
Water. Interestingly, no published critical micellar concen 
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tration (CMC) value could be found for polyoxyethylene 20 
stearyl ether. It is likely that the relatively heterogeneous 
nature of the polymeric surfactant makes the determination 
of its CMC difficult using conventional techniques. Photon 
correlation spectroscopy, using a Coulter N4 Plus Submi 
cron Particle SiZer, Was used to determine the existence and 
the siZe of the surfactant micelles. The results indicated that 
the surfactant does begin to form micelles (5—20 nm) 
betWeen a concentration of 0.5 mM to 1 mM in Water. 
HoWever, these micelles are clearly absent in the cured solid 
nanoparticles indicating that the 50—100 nm nanoparticles 
could be engineered directly from the microemulsion pre 
cursors. 
Example 2 
Preparation of polyoxyethylene 2 stearyl ether nanopar 
ticles. Three separate samples of polyoxyethylene 2 stearyl 
ether nanoparticles Were engineered using the folloWing 
process. Polyoxyethylene 2 stearyl ether (2 mg) Was melted 
at 50—55° C. and dispersed in 970 microliters of Water at the 
same temperature. Thirty microliters of solution of TWeen 
80 (10% v/v in Water) Was added to produce a clear 
oil-in-Water microemulsion at approximately 55° C. The oil 
droplet siZe of liquid polyoxyethylene 2 stearyl ether Was 
measured by photon correlation spectroscopy to be 22211.8 
nanometers at approximately 55° C. Polyoxyethylene 2 
stearyl ether nanoparticles Were cured by three different 
methods as folloWs: Method A) cooling of the undiluted 
oil-in-Water microemulsion at 55° C. to room temperature 
While stirring, Method B) cooling of the oil-in-Water micro 
emulsion at 55° C. by placing undiluted in a refrigerator at 
4° C., and Method C) diluting (1/ 10) the oil-in-Water micro 
emulsion at 55° C. With Water at 4° C. The results as shoWn 
in FIG. 2 demonstrate that the method of curing had no effect 
on the siZe of nanoparticles formed. Further, Method A 
illustrated a key advantage of simply alloWing the oil-in 
Water microemulsion to cool to room temperature to form 
useful solid nanoparticles. This method alloWs for rapid, 
reproducible, and cost-effective method to engineer useful 
nanoparticles. 
Example 3 
Preparation of Emulsifying Wax nanoparticles. Three 
separate samples of emulsifying Wax nanoparticles Were 
engineered using the folloWing process. Emulsifying Wax (2 
mg) Was melted at 50—55° C. and dispersed in 970 micro 
liters of Water at the same temperature. Thirty microliters 
100 mM polyoxyethylene 20 stearyl ether, Which is sold 
under the trademark Brij 78 Were added to produce a clear 
oil-in-Water microemulsion at approximately 55° C. The oil 
droplet siZe of liquid emulsifying Wax Was measured by 
photon correlation spectroscopy to be 24.5104 nanometers 
at approximately 55° C. Emulsifying nanoparticles Were 
cured by three different methods as folloWs: Method A) 
cooling of the undiluted oil-in-Water microemulsion at 55° 
C. to room temperature While stirring, Method B) cooling of 
the oil-in-Water microemulsion at 55° C. by placing undi 
luted in a refrigerator at 4° C., and Method C) diluting (1/ 10) 
the oil-in-Water microemulsion at 55° C. With Water at 4° C. 
The results as shoWn in FIG. 3 demonstrate that the method 
of curing had no effect on the siZe of nanoparticles formed. 
Further, Method A illustrated a key advantage of simply 
alloWing the oil-in-Water microemulsion to cool to room 
temperature to form useful solid nanoparticles. This method 
alloWs for rapid, reproducible, and cost-effective method to 
engineer useful nanoparticles. 
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Further, the solid nanoparticles made from Method A 
Were subjected to ultracentrifugation at 50,000 rpm for 30 
minutes. Photon correlation spectroscopy analysis shoWed 
that these ultracentrifugation conditions had no effect on the 
intensity of light scattering or particle siZe indicating a very 
stable colloidal suspension. 
Example 4 
Preparation of nanoscintillation systems containing ?uor 
molecules With a ?nal concentration of 1 mg/mL. PPO (1 
mg) Was entrapped in and effectively solubiliZed in 2 mg 
nanoparticles made from emulsifying Wax and a ?nal poly 
oxyethylene 20 stearyl ether concentration of 10 mM. Thus, 
the Weight composition of PPO Was 33% W/W (or 1 mg PPO 
per 3 mg total Weight). As measured by photon correlation 
spectroscopy (PCS), the entrapment of PPO in nanoparticles 
had no effect on particle siZe. Empty nanoparticles had a 
particle siZe of 65:23 nm and nanoparticles With PPO had 
a particle siZe of 65:24 nm. It Was also con?rmed that the 
nanoparticles containing PPO Were formed directly from an 
oil-in-Water microemulsion precursor since the droplet siZe 
of the matrix oil phase in the microemulsion at 52° C. Was 
measured by PCS to be 2019 nm. The use of 1% phenoxy 
ethanol in Water Was also investigated as a possible energy 
transfer agent to enhance detection efficiency. The incorpo 
ration of phenoxyethanol into the microemulsion precursors, 
and subsequently the cured nanoparticles, had no effect on 
resulting nanoparticle siZe or stability. The entrapment ef? 
ciency of PPO in cured nanoparticles can be determined by 
gel permeation chromatography by eluting 0.1—1.0 mL 
samples doWn hand-packed Sephadex G-75 columns (9 
cm><0.5 cm). In addition, the retention of PPO in cured 
nanoparticles can be monitored by placing GPC-eluted 
nanoparticles in sterile membrane dispodialyZers from Spec 
trum Laboratories (Rancho DomingueZ, Calif.) With 10 kDa 
molecular Weight cutoffs. 
Example 5 
Preparation of nanoscintillation systems containing ?uor 
molecules With a ?nal concentration of up to 4.3 mg/mL In 
order to increase the concentration of PPO in the 
nanoparticles, the procedure described in Example 4 Was 
folloWed to engineer nanoscintillation systems having PPO 
With a ?nal concentration of up to 4.3 mg/mL. For all 
samples, the ratio of emulsifying Wax to PPO Was ?xed at 
2:1 W/W. As shoWn in FIG. 4, the entrapment of PPO in 
nanoscintillation systems had little or no effect on the 
resulting particle siZe of the nanoparticles measured Within 
30 minutes after preparation. 
Example 6 
The feasibility of using the prototype nanoparticles con 
taining PPO as an aqueous-based liquid scintillation count 
ing system Was demonstrated by adding 20 microliters of 
14C-labeled sodium bicarbonate (NaH14CO3) to 3 mL 
samples and counting in a Packard 2200 CA Tri-Carb Liquid 
Scintillation AnalyZer (see Table 2 beloW). 
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TABLE 2 
Comparison of Prototype Aqueous-Based NanoScintillation 
Systems to Commercial Organic-Based Cocktails 
DPM % of % of 
Sample Detected Control #1 Control #2 
Nanoparticles With PPO (1 mg/mL) 2975 6.7% 0.9% 
in Water 
Nanoparticles With PPO (1 mg/mL) 4059 9.1% 1.2% 
in Water With 1% phenoxyethanol 
Water (negative control) 30 0.0% 0.0% 
Control #1: 44,456 100.0% N/A 
ScintiSafe Econo F 
(commercial cocktail) 
Control #2: 326,264 N/A 100.0% 
ScintiVerse LC 
(commercial cocktail) 
The results demonstrated that it Was feasible to detect 
radioactivity added to the nanoscintillation system, although 
the efficiency of detection of 14C Was only ~1—10% of that 
obtained When using tWo commercially available organic 
based cocktails. These commercial cocktails are highly 
optimized system containing PPO at a concentration of 5—7 
mg/mL, emulsifying agents, and secondary ?uor molecules 
such as bis-MSB and POPOP. The loW efficiency observed 
With the initial nanoscintillation system employed is not 
surprising When one considers the materials of Which the 
nanoparticles Were composed (i.e., emulsifying Wax and 
polyoxyethylene 20 stearyl ether. These materials might be 
expected to be chemical quenchers. Further, the energy 
spectra of the nanoscintillation system to Which 14C 
bicarbonate had been added Were shifted toWard the loW 
energy range. In addition, the nanoscintillation system con 
tained only 1 mg/mL of PPO. 
Example 7 
To determine the feasibility of adding ligand to the cured 
solid nanoparticles, asialofetuin-palmitate (ASF-pal) Was 
synthesized. Asialofetuin Was derivatized With about 12 
palmitate ‘arms’ per molecule as measured by a colorimetric 
hydroxamic acid reaction assay (Goddu, R. F., LeBlanc, N. 
E, Wright, C. M. Spectrophotometric determination of esters 
and anhydrides by hydroxamic acid reaction. Anal. Chem. 
27:1251—1255, 1955) ASF-pal (1—100 pL; 13.4 ug/mL 
Water) Was added to cured solid nanoparticles in Water so 
that the ?nal concentration of nanoparticles Was 200 pg 
nanoparticles per 1 mL. Stirring Was continued at 25° C. for 
a total of 1 hour to ensure complete adsorption/insertion of 
the palmitate arm of ASF-pal into the nanoparticles. The 
results as shoWn in FIG. 5 demonstrate that even very high 
concentrations of ASF-pal could be added to the nanopar 
ticles With only a small effect on the particle size. As 
controls, the particle size of ASF-pal alone in Water at a 
concentration of either 67 pg/mL or 1340 pg/mL Were 
measured. The results shoWed that ASF-pal formed micelles 
(3—15 nm) at 67 pg/mL At a concentration of 1340 pg/mL, 
ASF-pal formed a mixture of micelles (3—10 nm) as Well as 
larger aggregates (40—300 nm). It Was apparent from these 
results that a hydrophobized cell-speci?c targeting ligand 
could be added to cured nanoparticles. 
Example 8 
The formation of oil-in-Water microemulsions using sty 
rene as the oil phase: Microemulsions Were formed using 
styrene as the oil phase, polyoxyethylene 20 stearyl ether as 
the surfactant, and l-pentanol co-surfactant. The proportion 
of each component necessary for microemulsion formation 
Was studied. The primary ?uor molecule 2,5 
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diphenyloxazole (PPO) and secondary ?uor molecule p-bis 
(o-methylstyryl)-benzene (bis-MSB) Were dissolved in the 
styrene prior to microemulsion formation. After forming the 
microemulsion, the styrene Was polymerized using sodium 
persulfate as a free radical initiator and heating to 70° C. for 
8 hours to form a nanosuspension consisting of styrene 
nanoparticles entrapping PPO and bis-MSB. 
The formula to prepare the nanoscintillation system Was 
as folloWs 
80 mM polyoxyethylene 20 stearyl ether as surfactant 
2.5% (v/v) Styrene as oil phase 
5 mg/mL 2,5-diphenyloxazole (PPO) as primary ?uor 
0.125 mg/mLp-bis(o-methylstyryl)benzene (bis-MSB) as 
secondary ?uor 
224 mM l-pentanol as co-surfactant 
1 mM sodium persulfate as free radical initiator 
Water as the continuous phase This nanosuspension Was 
subsequently concentrated by a factor of ~2 using 
centrifugal ultra?ltration. Approximately 57,000 dpm 
of 14C-acetic acid (volume=50 pl) Was then added to 
the nanosuspension and it Was placed in a liquid 
scintillation counter. The number of radioactive counts 
(cpm) detected in the nanosuspension in the liquid 
scintillation counter Was compared to the cpm obtained 
When the same amount of 14C-acetic acid Was added to 
a conventional organic liquid scintillation cocktail and 
to Water (as a control). The results of these counting 
experiments are as folloWs: 
TABLE 3 
Counting E?iciency of Nanosuspension as 
Compared to Conventional Organic Cocktail 
E?iciency 
Sample (containing Relative to Overall 
~57,000 dpm of Conventional Counting 
14C-Acetic Acid cpm Cocktail E?iciency 
Conventional LSC Cocktail 50,814 — 89.1% 
Water 30 0.06% 0.05% 
Concentrated Nanosuspension 14,632 28.8% 25.7% 
Thus, the overall detection efficiency (counts per minute/ 
disintegrations per minute) of the concentrated nanosuspen 
sion for detecting Carbon-14 Was approximately 25 .7%. 
When increasing volumes of 14C-acetic acid (25—150 ML) 
Were added to 3 mL of the nanosuspension, a linear increase 
in the number of cpm detected Was observed as shoWn in 
FIG. 6 (and as summarized in Table 4 beloW). 
TABLE 4 
The Effect of Nanosuspension Concentration 
on the Counting E?iciency of Nanoscintillation 
Systems 
Volume of 14C-Acetic Cocktail Nanosuspension Nonosuspension/ 
Acid Added" (,uL) (cpm) (cpm) Cocktail ratio 
25 26881 7086 0.264 
50 50814 14632 0.288 
75 77279 21266 0.275 
100 100706 28025 0.278 
150 159858 41870 0.262 
*~1.14 X 106 dpm/mL 
Example 9 
The Formation of Oil-in-Water Microemulsions Using 
Increased Concentration of Styrene in the Oil Phase and 
Subsequent Formation of Nanosuspension: 
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The formula to prepare the nanoscintillation system Was 
as follows 
80 mM polyoxyethylene 20 stearyl ether as surfactant 
5.0% (v/v) Styrene as oil phase 
10 mg/mL 2,5-diphenyloxaZole (PPO) as primary ?uor 
0.25 mg/mL p-bis(o-methylstyryl)benZene (bis-MSB) as 
secondary ?uor 
224 mM 1-pentanol as co-surfactant 
1 mM sodium persulfate as free radical initiator 
Water as the continuous phase 
The microemulsion precursor Was prepared by dissolving 
PPO and bis-MSB in styrene and added this to an aqueous 
solution containing polyoxyethylene 20 stearyl ether and 
pentanol. This mixture Was heated to 45° C. for 15 minutes, 
cooled to room temperature and stirred for an additional 24 
hours. To this clear microemulsion Was added sodium per 
sulfate to initiate the polymeriZation of styrene. The poly 
meriZation reaction continued for 8 hours at 70° C. The 
mean particle siZe of the resulting nanosuspension Was 52.6 
nm as determined by photon correlation spectroscopy. 
This nanosuspension Was subsequently concentrated by a 
factor of ~2 using centrifugal ultra?ltration. Approximately 
91,000 dpm of 14C-acetic acid (volume 50=ul) Was then 
added to the 1.0 mL of this nanosuspension and it Was placed 
in a liquid scintillation counter. The number of radioactive 
counts (cpm) detected in the nanosuspension in the liquid 
scintillation counter Was compared to the cpm obtained 
When the same amount of 14C-acetic acid Was added to a 
conventional organic liquid scintillation cocktail and to 
Water (as a control). The results of these counting experi 
ments are as folloWs, summariZed in Table 5: 
TABLE 5 
Counting E?iciency of Nanosuspension as 
Compared to Conventional Organic Cocktail 
Sample 
(containing 
~91,000 dpm E?iciency Relative Overall Counting 
of 14C- to Conventional E?iciency 
Acetic Acid cpm Cocktail (cpm/dpm) 
Conventional 82,015 r 242 — 90.1% 
LSC 
Cocktail 
Concentrated 40,246 r 706 49.1% 44.2% 
Nano 
suspension 
With the bene?t of the present disclosure, those having 
skill in the art Will comprehend that techniques claimed 
herein and described above may be modi?ed and applied to 
a number of additional, different applications, achieving the 
same or a similar result. The claims attached hereto cover all 
such modi?cations that fall Within the scope and spirit of this 
disclosure. For example, although the description of this 
disclosure may name speci?c materials useful for the prac 
tice of the invention (e.g., speci?c materials useful as a 
surfactant or co-surfactant or ?uor molecule), those of 
ordinary skill in the art having the bene?t of this disclosure 
Will recogniZe that any derivative thereof, any equivalent, or 
any other material achieving the same or similar result may 
be substituted thereWith. Each of the folloWing references is 
hereby incorporated by reference in its entirety: 
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What is claimed is: 
1. A nanoscintillation system comprising nanoparticles 
suspended in an aqueous vehicle, the nanoparticles com 
prising: 
at least one nanoparticle matrix material 
at least one surfactant or co-surfactant or a mixture 
thereof, and 
at least one primary or secondary ?uor molecule or a 
mixture thereof. 
2. The nanoscintillation system of claim 1, the nanopar 
ticles having a diameter less than 300 nanometers. 
3. The nanoscintillation system of claim 1, the nanopar 
ticles having a diameter less than 100 nanometers. 
4. The nanoscintillation system of claim 1, further com 
prising an electron-emitting or alpha-particle-emitting radio 
isotope. 
5. The nanoscintillation system of claim 4, the electron 
emitting or alpha-particle-emitting radioisotope being free 
or attached to one or more molecules in the aqueous vehicle. 
6. The nanoscintillation system of claim 1, further com 
prising one or more ligands coupled to one or more of the 
nanoparticles. 
7. The nanoscintillation system of claim 6, the one or 
more ligands comprising a protein, carbohydrate, or a com 
bination thereof. 
8. The nanoscintillation system of claim 1, the nanopar 
ticle matrix material comprising emulsifying Wax, a poly 
oxyethylene sorbitan fatty acid ester, a polyoxyethylene 
alkyl ether, a polyoxyethylene stearte, or polystyrene or its 
derivative or copolymer thereof. 
9. The nanoscintillation system of claim 1, the nanopar 
ticle matrix material being present at a concentration from 
0.1 to 300 mg/mL. 
10. The nanoscintillation system of claim 1, the aqueous 
vehicle comprising Water or an aqueous buffer. 
11. The nanoscintillation system of claim 1, the surfactant 
or co-surfactant comprising a polyoxyethylene alkyl ether, a 
polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene 
stearate, an alkoxylated alcohol or its derivative thereof, or 
an alcohol. 
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12. The nanoscintillation system of claim 1, surfactants 
being present at a total concentration of 1—5000 mM. 
13. The nanoscintillation system of claim 1, the primary 
?uor molecule comprising 2,5 -diphenyloxaZole (PPO), 2-(4 
biphenylyl)-5-phenyl-1,3,4-oxadiaZole (PBD), 2-(4 
biphenylyl)-5-(4tert-butylphenyl)-1,3,4-oxadiaZole (butyl 
PBD), 2,5-bis(5-tert-butyl-2-benZoxaZolyl)thiophene 
(BBOT), or derivatives or combinations thereof. 
14. The nanoscintillation system of claim 1, the secondary 
?uor molecule comprising 1,4-bis(5-phenyloxaZol-2yl) 
benZene (POPOP), 1,4-bis(2-methylstyryl)benZene(bis 
MSB), or derivatives or combinations thereof. 
15. The nanoscintillation system of claim 1, primary ?uor 
molecules being present at a total concentration of at least 1 
mg/mL. 
16. The nanoscintillation system of claim 1, Water com 
prising at least 50% of the total Weight of the nanoscintil 
lation system. 
17. A method for scintillation measurement, comprising: 
obtaining a nanoscintillation system according to claim 1; 
and 
measuring scintillation associated With the nanoscintilla 
tion system. 
18. A nanoparticle comprising: 
at least one nanoparticle matrix material; 
at least one surfactant or co-surfactant or a mixture 
thereof, and 
at least one primary or secondary ?uor molecule or a 
mixture thereof; 
Wherein the nanoparticle is made from an oil-in-Water 
microemulsion precursor. 
19. The nanoparticle of claim 18, the nanoparticle being 
made by cooling the oil-in-Water microemulsion to room 
temperature While stirring. 
20. The nanoparticle of claim 18, the nanoparticle com 
prising an emulsifying Wax, a polyoxyethylene sorbitan fatty 
acid ester, a polyoxyethylene alkyl ether, a polyoxyethylene 
stearate, polystyrene, or derivatives or combinations thereof. 
21. The nanoparticle of claim 18, the nanoparticle com 
prising polystyrene, a copolymer of polystyrene, or a deriva 
tive thereof and having a melting point betWeen 40° C. and 
80° C. 
22. The nanoparticle of claim 18, the nanoparticle com 
prising styrene, divinyl benZene, toluene, an aromatic or 
unsaturated monomer capable of being polymeriZed by one 
or more free radicals, or a derivative or combination thereof. 
23. The nanoparticle of claim 18, the nanoparticle being 
present at a concentration from 0.1 to 300 mg/mL. 
24. The nanoparticle of claim 18, the surfactant or 
co-surfactant comprising a polyoxyethylene alkyl ether, a 
polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene 
stearate, an alkoxylated alcohol or its derivative thereof, or 
an alcohol. 
25. The nanoparticle of claim 18, surfactants being 
present at a total concentration of 1—5000 mM. 
26. The nanoparticle of claim 25, surfactants being 
present at a total concentration of 1—300 mM. 
27. The nanoparticle of claim 18, the primary ?uor 
molecule comprising 2,5-diphenyloxaZole (PPO), 2-(4 
biphenylyl)-5-phenyl-1,3,4-oxadiaZole (PBD), 2-(4 
biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiaZole (butyl 
PBD), 2,5-bis(5-tert-butyl-2-benZoxaZolyl)thiophene 
(BBOT), or derivatives or combinations thereof. 
28. The nanoparticle of claim 18, the secondary ?uor 
molecule comprising 1,4-bis(5-phenyloxaZol-2yl)benZene 
(POPOP), 1,4-bis(2-methylstyryl)benZene (bis-MSB), or 
derivatives or combinations thereof. 
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29. The nanoparticle of claim 18, primary ?uor molecules 
being present at a total concentration of at least 1 mg/mL. 
30. The nanoparticle of claim 18, the nanoparticle being 
made by polymerizing the nanoparticle matrix material 
Within the oil-in-Water microemulsion precursor by free 
radical polymeriZation. 
31. The nanoparticle of claim 30, free-radical polymer 
iZation being performed by heating the oil-in-Water micro 
emulsion precursor, by adding a free-radical initiator, or by 
a combination thereof. 
32. A method for scintillation measurement, comprising: 
obtain a nanoparticle according to claim 18; and 
measuring scintillation associated With the nanoparticle. 
33. A method of making a nanoscintillation system, 
comprising: 
dispersing a liquid nanoparticle matrix material With a 
?uor molecule in an aqueous continuous phase to form 
a surfactant stabiliZed microemulsion; and 
cooling the surfactant stabiliZed microemulsion to room 
temperature While stirring. 
34. A method of making a nanoparticle useful for 
scintillation, comprising: 
obtaining a nanoparticle matrix material; 
melting the nanoparticle matrix material to form a liquid 
dispersed phase; 
dispersing a ?uor molecule into the liquid dispersed 
phase; 
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dispersing the liquid dispersed phase, including the ?uor 
molecule, in an aqueous continuous phase to form a 
surfactant stabiliZed microemulsion; and 
cooling the microemulsion While stirring to form a solid 
stable nanoparticle having a diameter of less than about 
300 nanometers, Which includes the ?uor molecule 
either entrapped in or adsorbed to the nanoparticle. 
35. The method of claim 34, the melting occurring at a 
temperature betWeen about 35° C. and about 100° C. 
36. The method of claim 34, the cooling comprising 
cooling With no dilution in Water. 
37. A method of making a nanoscintillation system, 
comprising: 
dispersing a liquid nanoparticle matrix material With a 
?uor molecule in an aqueous continuous phase to form 
a surfactant stabiliZed microemulsion; and 
polymeriZing the liquid nanoparticle matrix material by 
free-radical polymeriZation. 
38. The method of claim 37, the free-radical polymeriZa 
tion being performed by heating the surfactant stabiliZed 
microemulsion, by adding a free-radical initiator, or by a 
combination thereof. 
39. The method of claim 37, further comprising concen 
trating the nanoscintillation system. 
40. The method of claim 39, the concentrating comprising 
centrifugal ultra?ltration. 
* * * * * 

